MSP Recovery Return on Tangible Equity 2020-2024 | MSPR

Current and historical return on tangible equity values for MSP Recovery (MSPR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
MSP Recovery Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.10B $-1.93B 5.34%
2024-06-30 $-0.09B $-1.86B 5.01%
2024-03-31 $-0.07B $-1.77B 4.20%
2023-12-31 $-0.06B $-1.71B 3.51%
2023-09-30 $-0.02B $-1.61B 1.58%
2023-06-30 $-0.01B $-1.57B 2.18%
2023-03-31 $0.00B $-1.48B 0.10%
2022-12-31 $-0.01B $-1.18B -0.59%
2022-09-30 $-0.04B $3.32B -2.38%
2022-06-30 $-0.05B $3.32B -6.04%
2022-03-31 $-0.05B $-0.02B 75.00%
2021-12-31 $-0.03B $-0.24B 51.82%
2021-06-30 $-0.00B $0.01B 133.33%
2021-03-31 $0.01B $0.01B -181.82%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.018B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.209B 54.83
Hims & Hers Health (HIMS) United States $15.018B 381.89
Tempus AI (TEM) United States $13.495B 0.00
Inspire Medical Systems (INSP) United States $5.303B 103.31
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Schrodinger (SDGR) United States $1.895B 0.00
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00